13F HOLDINGS REPORT
Pivotal bioVenture Partners Investment Advisor LLC
Quarter ended Q1 2023 · Filed February 13, 2023 · Accession 0001012975-23-000082
Total Value
$230.0M
Positions
10
Other Managers
1
Confidential Omitted
No
Holdings (10)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | KARUNA THERAPEUTICS INC | 48576A100 | 765,895 | $150.5M | 65.45% |
| 2 | VAXCYTE INC | PCVX | 693,039 | $33.2M | 14.45% |
| 3 | RALLYBIO CORP | RLYB | 2,404,644 | $15.8M | 6.87% |
| 4 | ARCUTIS BIOTHERAPEUTICS INC | ARQT | 569,041 | $8.4M | 3.66% |
| 5 | VIGIL NEUROSCIENCE INC | 92673K108 | 560,595 | $7.0M | 3.05% |
| 6 | FUSION PHARMACEUTICALS INC | 36118A100 | 1,560,984 | $4.9M | 2.14% |
| 7 | EXSCIENTIA PLC | 30223G102 | 772,285 | $4.1M | 1.79% |
| 8 | INOZYME PHARMA INC | 45790W108 | 2,661,154 | $2.8M | 1.22% |
| 9 | BOLT BIOTHERAPEUTICS INC | BOLT | 1,891,467 | $2.5M | 1.07% |
| 10 | ALIGOS THERAPEUTICS INC | ALGS | 743,215 | $708,284 | 0.31% |